P

Prothena Corp
D

PRTA

14.590
USD
0.16
(1.11%)
Market Closed
Volume
9,077
EPS
-2
Div Yield
-
P/E
-6
Market Cap
785,069,400
OverviewSignalsIdeasNews
Related Instruments
    ALNY
    ALNY
    -22.650
    (-8.77%)
    235.480 USD
    B
    BLUE
    -0.04270
    (-11.74%)
    0.32090 USD
    BMY
    BMY
    -2.270
    (-3.88%)
    56.230 USD
    GILD
    GILD
    -3.715
    (-4.03%)
    88.385 USD
    I
    IMUX
    -0.03500
    (-3.23%)
    1.05000 USD
    I
    INCY
    -1.840
    (-2.37%)
    75.890 USD
    MRNA
    MRNA
    -2.950
    (-7.42%)
    36.830 USD
    REGN
    REGN
    -25.40
    (-3.25%)
    756.82 USD
    S
    SGEN
    0
    (0%)
    0.000000 USD
    VRTX
    VRTX
    -18.53
    (-3.83%)
    450.72 USD
    More
News

Title: Prothena Corp

Sector: Healthcare
Industry: Biotechnology
Prothena Corp PLC is a biotechnology company that focuses on protein dysregulation and a pipeline of investigational therapeutics with the potential to change the course of devastating rare neurodegenerative and peripheral amyloid diseases. The company's clinical pipeline of antibody-based product candidates targets a range of indications, including Amyloid Light-chain (AL) amyloidosis (NEOD001), Parkinson's disease and other related synucleinopathies (PRX002), and inflammatory diseases, including psoriasis and psoriatic arthritis (PRX003) and ATTR amyloidosis (PRX004).